Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm
Objective: To study demographic and clinical features of primary and secondary hemifacial spasm and assess their response to botulinum toxin therapy. Background: Hemifacial spasm (HFS)…Unusual facial synkinesia after Bell’s palsy: interactive Marin-Amat syndrome proven by surface electromyogram, successfully treated with low dose botulinum toxin A.
Objective: To clarify unusal facial synkinesia by using surface electromyogram and botulinum toxin A. Background: Marin-Amat syndrome is a facial synkinesis manifesting as involuntary eyelid…The clinical and neuroimaging analysis in hemifacial spasm with associated cranial neuropathy: retrospective case series study
Objective: To evaluate the clinical characteristics and neuroimaging findings observed in the association between hemifacial spasms (HFS) and other cranial neuropathy in a cohort of…Differences between Hemifacial spasm with or without neurovascular conflict. Therapeutic implications with botulinum toxin type A.
Objective: To evaluate the presence of possible clinical differences between patients with HS with and without neurovascular conflict (NVC +, NVC-) and their therapeutic response…Prevalence of Babinski-2 sign in Hemifacial Spasm Patients
Objective: To assess the frequency of Babinski-2 sign among patients with hemifacial spasm (HFS). Background: The Babinski-2 sign (“the other” Babinski sign, “brow-lift sign”), is…Prevalence of hemifacial spasm in Northern Cyprus
Objective: To estimate the prevalence and analyze the clinical profile of hemifacial spasm in Northern Cyprus. Background: Hemifacial spasm (HFS) is characterized by involuntary, clonic…Hemifacial spasm – Therapeutic assessment of botulinum toxin
Objective: To evaluate the long-term effect of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm (HFS) in a large group of patients…Hemifacial spasm: Objective computation of vertebrobasilar vascular sinuosity
Objective: To objectively compute the degree of vascular sinuosity in the vertebrobasilar arteries in hemifacial spasm (HFS) and control subjects using a case-control MRI/A approach.…Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm
Objective: The two primary objectives of this study were to investigate the structural grey matter changes and connectivity differences between patients with BEB and HFS…Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II
Objective: To evaluate the therapeutic and preventive effect of OnabotulinumtoxinA (BoNT/A) in the treatment of hemifacial spasm, bruxism, and trigeminal neuralgia post Ramsay Hunt Syndrome.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.